§ 50-32-201 General criteria to be considered
§ 50-32-202 Designation of drug as dangerous drug
§ 50-32-203 Effect of rescheduling under federal law
§ 50-32-204 Immediate precursors
§ 50-32-205 Nonprescription drugs not to be scheduled
§ 50-32-206 Use of names of scheduled drugs
§ 50-32-207 Order forms for drugs in Schedules I and II
§ 50-32-208 Prescription and medical requirements for scheduled drugs — penalty
§ 50-32-209 Republication of schedules
§ 50-32-221 Criteria for placement of drug in Schedule I
§ 50-32-222 Specific dangerous drugs included in Schedule I
§ 50-32-223 Criteria for placement of drug in Schedule II
§ 50-32-224 Specific dangerous drugs included in Schedule II
§ 50-32-225 Criteria for placement of drug in Schedule III
§ 50-32-226 Specific dangerous drugs included in Schedule III
§ 50-32-227 Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III
§ 50-32-228 Criteria for placement of drug in Schedule IV
§ 50-32-229 Specific dangerous drugs included in Schedule IV
§ 50-32-230 Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV
§ 50-32-231 Criteria for placement of drug in Schedule V
§ 50-32-232 Specific dangerous drugs included in Schedule V
§ 50-32-233 Exempt anabolic steroid products